Masimo Launches Sepsis Index in Limited Release

Masimo has begun limited market release of its Sepsis Index (Si) early warning indicator to help identify possible sepsis in patients being remotely monitored with Masimo’s Patient SafetyNet.
 
Si quantifies patient status in an easily interpretable sepsis risk score by continuously analyzing vital signs data and other clinical measurements with EMR data captured by Patient SafetyNet. It displays on-screen decision support and recommended actions that each institution using it can update according to sepsis policy. The Si algorithm is customizable, as well.
 
Aldo Carmona, MD, senior VP of clinical innovation and Chairman of the Department of Anesthesia and Critical Care at St. Luke’s University Health Network, told the press, “Although there have been great advancements both clinically and technically, assessment and early identification of sepsis remain an elusive challenge. Masimo’s new indicator, Si, provides a continuous and real-time assessment of sepsis risk for a given patient based on the clinical measurements available from monitors and other EMR data (labs, medications, etc.). This could be a great addition in a hospital’s fight against the leading cause of in-patient mortality. By alerting the clinical staff to the risk of potential sepsis, it would allow for more timely intervention with life-saving resuscitation and medication. Likewise, tracking the patient state will help assess the effects of treatment and interventions so that we can improve appropriate allocation of hospital resources to patients and potentially identify patients who need escalation of treatment earlier.”
 
Joe Kiani, founder and CEO of Masimo added, “Masimo has always sought to solve those ‘unsolvable’ problems that need resolution. Detection of sepsis has long been one of the unsolved clinical problems, and one which we have spent considerable time and effort to remedy. With Sepsis Index, we hope to help doctors and nurses everywhere identify sepsis before it’s too late to treat it.”
 
Si is not yet FDA cleared.